Last reviewed · How we verify
NCT07089238
Evaluate the Effects of Citicoline on Mood in Healthy Adults
NA trial testing Citicoline in Healthy in 90 participants. Currently enrolling.
31 March 2026
Quick facts
| Lead sponsor | Kirin Holdings Company, Limited |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | health services research |
| Enrollment | 90 |
| Start date | 31 July 2025 |
| Primary completion | 31 March 2026 |
| Estimated completion | 31 March 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Citicoline (CITICOLINE) — full drug profile →
- Placebo
Conditions studied
- Healthy — all drugs for Healthy →
Sponsor
Kirin Holdings Company, Limited — full company profile →
Who can join
Adults 21 to 65, any sex, with Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this trial is to determine the effects of citicoline on mood in healthy Men and Women compared to a placebo.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07089238
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Citicoline
Trials testing the same drug.
- NCT05881135 — Supplemental Citicoline Administration to Reduce Lung Injury Efficacy Trial (SCARLET) · Phase 1, PHASE2 · active not recruiting
- NCT03949049 — Citicoline as Neuroprotector in Neonates Exposed to Hypoxia · Phase 3 · recruiting
- NCT04003090 — Citicoline Concentration in Human Vitreous · NA · completed
- NCT03758118 — Citicoline in Non-Arteritic Ischemic Optic Neuropathy · NA · completed
- NCT05527106 — Evaluation of the Effect of Citicoline and Docosahexaenoic Acid (DHA) on the Visual Function of Patients With Glaucoma · NA · completed
Other recruiting trials for Healthy
Currently open trials in the same condition.
- NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
- NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
- NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
- NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
- NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting
Other Kirin Holdings Company, Limited trials
Trials by the same sponsor.
- NCT06906848 — Evaluate the Effects of Citicoline on Cognitive Performance in Healthy Adults · NA · completed
- NCT04967157 — Cognitive Effects of Citicoline on Attention in Healthy Mean and Women · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07089238 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kirin Holdings Company, Limited
- Last refreshed: 2 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07089238.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing